Our understanding of the complete drug development continuum helps you design, implement and execute renal research studies in all clinical phases more efficiently.

Renal research experts

Frenova’s renal research professionals serve as your single point of contact to streamline communication and ensure consistency, efficiency and quality across all sites, shortening the path to study completion.

Frenova works with hundreds of research groups, associations and service providers worldwide and leads national studies with partners around the globe. Over the years, we’ve established preferred relationships that enable us to capitalize on the strengths of our partners and deliver the best renal research talent available.

Sites support your study

By assessing competing trials, we ensure that selected sites will meet enrollment goals. Supported by experienced nephrology research coordinators and principal investigators, we work side by side with sites to operationalize research activities and align teams with your expectations.

When rapid startup is imperative, look to our select F1RST Up® sites primed for fast initiation and activation.

Frenova’s Renal Site Network

450 PRINCIPAL INVESTIGATORS
260 SITES
160 MEDICAL PRACTICES
700 DIALYSIS CLINICS

Access to patients

Our exclusive access to FMCNA, including nearly 2,500 dialysis clinics, allows us to reach nearly 200,000 ESRD patients and hundred of thousands of CKD patients.

No other clinical development services provider has a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do.

When you need to conduct a complete renal clinical program, start with the patient in mind — and trust the partner that’s completely renal.

Related Resources

Case Study

Frenova Helps With Business, Allows Principal Investigator to Focus on Care

Clinical investigators regularly report that logistical barriers hinder their conduct of clinical trials. Physician and staff workload balance, the time...

Article

Research as Care

Author: Kurt Mussina, MBA Fresenius Medical Care Newsroom | August 14, 2018 Speed is key in bringing new drugs to...

Article

F1RST Up®: Accelerating Clinical Trial Start-Up

Authors: Kurt Mussina, MBA & Christina Kahn ACRP Clinical Researcher | June 22, 2018 Despite the pressing need to bring...